8-K

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

         Date of Report (Date of earliest event reported) July 15, 2004

                             BSD MEDICAL CORPORATION
             (Exact name of registrant as specified in its charter)

            Delaware                        0-10783                 75-1590407
- --------------------------------------------------------------------------------
(State or other jurisdiction of           (Commission             (IRS Employer
         incorporation)                   File Number)           Identification)

                              2188 West 2200 South
                           Salt Lake City, Utah 84119
          (Address of principal executive offices, including Zip Code)

       Registrant's telephone number, including area code: (801) 972-5555

                                       N/A
          (Former name or former address, if changed since last report)



Item 7. Financial Statements and Exhibits.

(c)   Exhibits

99.1  Press Release of BSD Medical Corporation dated July 15 2004.

Item 9. Regulation FD Disclosure.

      BSD Medical  Corporation issued a press release on July 15 2004. A copy of
the press release is hereby furnished as Exhibit 99.1 attached hereto.



                                   SIGNATURES

      Pursuant to the  requirements of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

Dated: July 15, 2004

                                               By: /s/ Hyrum A. Mead
                                                   -----------------------------
                                                   President



                                  EXHIBIT INDEX

Exhibit No.                                Description
- -----------      ---------------------------------------------------------------
99.1             Press Release of BSD Medical Corporation dated July 15,  2004.

EX-99.1

                                                                    Exhibit 99.1

 BSD Medical Corporation Concludes the Sale of Its Holdings in TherMatrx, Inc.

    SALT LAKE CITY, July 15 /PRNewswire-FirstCall/ -- BSD Medical Corp.
(OTC Bulletin Board: BSDM) today reported that American Medical Systems
Holdings, Inc. has completed the acquisition of TherMatrx, Inc.  The sale
includes all of BSD Medical's holdings in TherMatrx.

    BSD will receive an initial payment of approximately $9 million in cash
(after the withholding of escrow funds and the payment of other initial
obligations) plus contingent payments based on TherMatrx sales made between
July 5, 2004 and December 31, 2005.  While the contingent payments must be
earned based on future sales of TherMatrx products, BSD has projected that if
TherMatrx sales were to remain flat at recent sales rates, the total payment
(including the initial payment) for BSD's shares in TherMatrx would be about
$30 million by the conclusion of the earn-out period.  Since TherMatrx sales
have been growing substantially year-on-year (up to $9.7 million in the first
half of 2004 compared to $6.7 million in the first half of 2003), the company
projects a total payout in the range of $40 million from the sale.


    American Medical Systems, headquartered in Minnetonka, Minnesota, is a
diversified supplier of medical devices and procedures to cure erectile
dysfunction, benign prostatic hyperplasia, incontinence and other pelvic
disorders in men and women.  The company's products were used to treat over
100,000 patients in 54 countries during the last year.  More information about
American Medical Systems and its products may be found at
www.AmericanMedicalSystems.com.


    TherMatrx is focused on providing physicians with an in-office alternative
for treating benign prostatic hyperplasia (BPH).  The technology used by
TherMatrx was originally developed by BSD Medical Corporation.  BSD Medical is
a foremost leader in the development of thermal therapies for medical use
delivered by microwave energy.  BSD's primary therapies are centered on the
treatment of cancer.  For more information about BSD Medical visit
www.BSDMC.com.


    Statements about contingent payments are forward-looking statements
subject to risks and uncertainties dependant on the future sales level of
TherMatrx products.  These risks and others are more fully described in the
company's Form 10-KSB filing for the year ended August 31, 2003, and its other
SEC filings.  All such forward-looking statements are subject to risks and
uncertainties, and actual results may differ materially from anticipated
results.



SOURCE  BSD Medical Corp.
    -0-                             07/15/2004
    /CONTACT:  Hyrum A. Mead of BSD Medical Corp., +1-801-972-5555, or fax,
+1-801-972-5930, investor@bsdmc.com/
    /Web site:  http://www.AmericanMedicalSystems.com /
    /Web site:  http://www.bsdmc.com /
    (BSDM)

CO:  BSD Medical Corp.; American Medical Systems Holdings, Inc. ; TherMatrx,
     Inc.
ST:  Utah
IN:  HEA MTC OTC
SU:  TNM